Patent · US Active

Methods of treating conditions involving elevated inflammatory response

US11179412B2 · kind B2 · utility

0Cited by

4References

10Claims

0Family size

Assignee

University of Pittsburgh—Of the Commonwealth System of Higher Education · US

Inventors

Daolin Tang · Dallas, US
Timothy Billiar · Pittsburgh, US
Ling Zeng · Chongqing, CN

Key dates

Filing date	Dec 4, 2018
Grant date	Nov 23, 2021
Priority date	—
Expiry date	Dec 4, 2038

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A method of treating a patient having an elevated inflammatory response, such as an elevated Type I interferon response, is provided. The method can be used to treat sepsis. The method comprises administering to a patient having an elevated inflammatory response, an inhibitor of anaplastic lymphoma kinase (ALK inhibitors) or expression of ALK, in an amount effective to treat the elevated inflammatory response.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.